Items where Author is "Ghaffary, E. M."
![]() | Up a level |
Article
(2025) Clinical and psychological factors associated with fear of relapse in people with multiple sclerosis: A cross-sectional study. Journal of Clinical Neuroscience. p. 8. ISSN 0967-5868
(2025) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 25. ISSN 0340-5354
(2025) The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. p. 9. ISSN 0022-510X
(2024) The Association of Salivary Cortisol Levels With Depression, Anxiety, and Quality of Life in Male Relapsing-Remitting Multiple Sclerosis Patients: A Case-Control Study. Acta Neurologica Scandinavica. p. 11. ISSN 0001-6314
(2024) Bone loss and fracture in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 11. ISSN 2211-0348
(2024) Cognitive performance and magnetic resonance imaging in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 9. ISSN 2211-0348
(2024) Concurrent glioma and multiple sclerosis: A systematic review of case reports. Multiple Sclerosis and Related Disorders. p. 10. ISSN 2211-0348
(2024) Hypertension in Multiple Sclerosis: Prevalence, Risk Determinants, and Disease Associations - A Systematic Review and Meta-analysis. Multiple Sclerosis Journal. pp. 795-796. ISSN 1352-4585
(2024) Multiple sclerosis and personality traits: associations with depression and anxiety. European Journal of Medical Research. p. 8. ISSN 0949-2321
(2024) Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis. Plos One. p. 20. ISSN 1932-6203
(2024) Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 16. ISSN 2211-0348
(2024) Onabotulinum toxin A improves neurogenic detrusor overactivity following spinal cord injury: a systematic review and meta-analysis. Spinal Cord. pp. 285-294. ISSN 1362-4393
(2024) Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer. Cancers. p. 22.
(2024) Safety and Efficacy of COVID-19 Vaccines Among Patients with Multiple Sclerosis: Letter to Editor. International Journal of Preventive Medicine. p. 2. ISSN 2008-7802
(2024) The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study. European Journal of Medical Research. p. 11. ISSN 0949-2321
(2023) Fingolimod-induced bladder lymphoma in a patient with multiple sclerosis. Clinical Case Reports. p. 4. ISSN 2050-0904
(2023) Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Revue Neurologique. pp. 265-281. ISSN 0035-3787
(2023) Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis. pp. 463-473. ISSN 0929-5305
(2023) Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review. Journal of Central Nervous System Disease. p. 15. ISSN 1179-5735
(2023) Neurosarcoidosis in an adult man with a family history of MS: A case report. Clinical Case Reports. p. 6. ISSN 2050-0904
(2023) Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis. Journal of the Neurological Sciences. p. 10. ISSN 0022-510X
(2023) Safety and efficacy of mesenchymal stem cell therapy in patients with multiple sclerosis during short- and long-term follow-up: a systematic review and meta-analysis. Multiple Sclerosis Journal. p. 1022. ISSN 1352-4585
(2023) Sociodemographic and Neuroimaging Evaluation of Patients with Multiple Sclerosis and Radiologically Isolated Syndrome in Isfahan, Iran. Archives of Neuroscience. p. 8. ISSN 2322-3944
(2023) Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurological Sciences. pp. 1905-1915. ISSN 1590-1874
(2022) COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis. NEUROLOGICAL SCIENCES. pp. 4085-4094. ISSN 1590-1874 1590-3478 J9 - NEUROL SCI
(2022) Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS
(2022) Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS
(2022) Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review. Canadian Journal of Infectious Diseases & Medical Microbiology. p. 7. ISSN 1712-9532
(2022) Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review. J Clin Neurosci. pp. 118-125. ISSN 0967-5868 (Print) 0967-5868
(2022) Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS